Charles S. Cleeland, Jeff A. Sloan, David Cella, Connie Chen, Amylou C. Dueck, Nora A. Janjan, Astra M. Liepa, Rajiv Mallick, Ann O'Mara, Jay D. Pearson, Yasuhiro Torigoe, Xin Shelley Wang, Loretta A. Williams and Jeanie F. Woodruff Recommendations for including multiple symptoms as endpoints in cancer clinical trials Cancer 119
Article first published online: 28 AUG 2012 | DOI: 10.1002/cncr.27744
The ASCPRO (Assessing the Symptoms of Cancer Using Patient-Reported Outcomes) Multisymptom Task Force examines the measurement of multiple symptoms as cancer clinical trials outcomes. This report defines a multisymptom outcome; addresses source attribution and the need for a hypothesis-driven, conceptual framework to measure multisymptom outcomes; and recommends methods for using multiple, individual symptom scores or composite scores as outcomes.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field
Copyright © 1999–2013 John Wiley & Sons, Inc. All Rights Reserved.